Identification of new protein-coding potential in Leishmania donovani using a proteogenomics approach
Current Microbiology · 2026
DOI: 10.1007/s00284-026-05095-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Soumi Chowdhury und 5 weiteren Autor:innen. Beteiligte Einrichtung: Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India. Hauptthemen laut MEDLINE: Leishmania donovani, Proteogenomics, Protozoan Proteins. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Leishmania donovani, the causative agent of visceral leishmaniasis, possesses a highly plastic genome and relies extensively on post-transcriptional regulation, posing challenges for accurate genome annotation. Despite the availability of a high-quality reference genome, many protein-coding genes remain incomplete or misannotated. While proteogenomic workflows have been previously applied to other Leishmania species, their application to the L. donovani CL-SL strain, which exhibits distinct genomic and disease-associated features, remains limited. In this study, we utilised a proteogenomic strategy integrating high-resolution tandem mass spectrometry (MS/MS) data with a custom six-frame translated genome database to re-analyse and refine the strain-specific genome annotation of L. donovani. This study is based on the systematic re-analysis of previously published proteomic datasets originally derived from the L. donovani DD8 strain and cross-mapped to the closely related L. donovani CL-SL reference assembly. By utilising stringent selection criteria, this study enables the extraction of additional, high-confidence annotation-level insights beyond the scope of the original analyses, while remaining cautious of localised, strain-specific sequence variations. Re-analysing published proteomics identified 50 N-terminal extensions and 15 novel coding regions. Many show orthology in related species and contain functional domains linked to metabolism, trafficking, or stress responses. These findings represent structural refinements to existing gene models, awaiting further experimental validation. Collectively, our findings demonstrate that proteogenomic integration significantly improves the accuracy of L. donovani genome annotation by resolving truncated gene models and uncovering hidden coding potential. These findings improve genome annotation and highlight previously unrecognised coding potential supported by peptide evidence in Leishmania donovani.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
- Institute of Bioinformatics, International Technology Park Limited, Whitefield, Bangalore, 560066, India.
- Molecular Arthopod Research Lab (MARL), Entomology Department, ICMR- Regional Medical Research Centre (ICMR-RMRC), Gorakhpur, India.
- Translational Health Science and Technology Institute (THSTI), Faridabad, 576104, Uttar Pradesh, India.
- Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India. harsh@ibioinformatics.org.
- Institute of Bioinformatics, International Technology Park Limited, Whitefield, Bangalore, 560066, India. harsh@ibioinformatics.org.
Zitieren
APA
Chowdhury, S., Pawar, S., Vasudevan, K., Mishra, N., Jamdhade, M., & Pawar, H. (2026). Identification of new protein-coding potential in Leishmania donovani using a proteogenomics approach. Current Microbiology. https://doi.org/10.1007/s00284-026-05095-7
Vancouver
Chowdhury S, Pawar S, Vasudevan K, Mishra N, Jamdhade M, Pawar H. Identification of new protein-coding potential in Leishmania donovani using a proteogenomics approach. Current Microbiology. 2026. doi:10.1007/s00284-026-05095-7
BibTeX
@article{Chowdhury2026,
author = {Chowdhury, Soumi and Pawar, Shubhankar and Vasudevan, Karthick and Mishra, Nalini and Jamdhade, Mahendra and Pawar, Harsh},
title = {Identification of new protein-coding potential in Leishmania donovani using a proteogenomics approach},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-05095-7}
}
EUVIMED